Levels of Evidence Needed for Changing Indications, Contraindications, and Food and Drug Administration Labeling: The Case of Metformin—Reply
Roussel R, Bhatt DL, Steg P, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators.
Arch Intern Med. 2011;171(11):1042-1043.
Published online June 13, 2011
Select Pricing Criteria:
Choose criteria for pricing info
Want online access for an institution? Learn More/Request Quote >